Skip to main content

NCCN Guidelines Insights: Bladder Cancer, Version 5.2018.

The NCCN Clinical Practice Guidelines in Oncology for Bladder Cancer provide recommendations for the diagnosis, evaluation, treatment, and follow-up of patients with bladder cancer. These NCCN Guidelines Insights discuss important updates to the 2018 version of the guidelines, including implications of the 8th edition of the AJCC Cancer Staging Manual on treatment of muscle-invasive bladder cancer and incorporating newly approved immune checkpoint inhibitor therapies into treatment options for patients with locally advanced or metastatic disease.


Flaig, TW, Spiess, PE, Agarwal, N, Bangs, R, Boorjian, SA, Buyyounouski, MK, Downs, TM, Efstathiou, JA, Friedlander, T, Greenberg, RE, Guru, KA, Hahn, N, Herr, HW, Hoimes, C, Inman, BA, Jimbo, M, Kader, AK, Lele, SM, Meeks, JJ, Michalski, J, Montgomery, JS, Pagliaro, LC, Pal, SK, Patterson, A, Petrylak, DP, Plimack, ER, Pohar, KS, Porter, MP, Preston, MA, Sexton, WJ, Siefker-Radtke, AO, Tward, J, Wile, G, Johnson-Chilla, A, Dwyer, MA, and Gurski, LA. "NCCN Guidelines Insights: Bladder Cancer, Version 5.2018." Journal of the National Comprehensive Cancer Network : Jnccn 16, no. 9 (September 2018): 1041-1053.

Published Date: 
Saturday, September 1, 2018
Published In: 
Jnccn Journal of the National Comprehensive Cancer Network